1/5 BREAKING NEWS: Novartis pays $2B upfront to acquire Synnovation Therapeutics's pan-mutant-selective PI3Kα inhibitor program — a strategic bet to defend its breast cancer franchise. 🧵
Joanna Sadowska aka Dr Jojo 🌸
@jmsadowska
a) Engineer
b) Scientific communicator
c) Pharma analyst
d) All of the above
My newsletter: joannasadowska.substack.com/subscribe
b) Scientific communicator
c) Pharma analyst
d) All of the above
My newsletter: joannasadowska.substack.com/subscribe
1.1K Following 959 Followers 536 Posts
Latest posts 5
1/7 These drugs generated the highest sales in 2025 — and 2025 marked a genuine shift in who holds the power. 🧵
1/6 BIG NEWS: Johnson & Johnson reports an 89% complete response rate with intravesical targeted therapy in early-stage bladder cancer 🧵
Which drugs drove the most revenue for pharma giants in 2025?
I mapped the top 3 selling medicines across 12 major companies - from $41B to $65B in revenue.
Here's what the data tells us 🧵
I mapped the top 3 selling medicines across 12 major companies - from $41B to $65B in revenue.
Here's what the data tells us 🧵
AstraZeneca released its FY24 financials, showing strong growth across its portfolio. Here's a quick breakdown of its performance